Literature DB >> 32306294

Treatment of moderate-to-severe and active Graves' orbitopathy: a step forward from the OPTIC study.

M L Tanda1, D Gallo1, S Ippolito1, L Bartalena2, E Piantanida1.   

Abstract

Keywords:  Exophthalmos; Graves’ disease; Graves’ orbitopathy; IGF-1 receptor; Teprotumumab; Thyroid eye disease

Mesh：

Substances：

Year:  2020        PMID： 32306294     DOI： 10.1007/s40618-020-01223-7

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  1 in total

1.  Graves' orbitopathy in Natalie Frank's oeuvre.

Authors:  M L Tanda; F Trimarchi
Journal:  J Endocrinol Invest       Date:  2021-03-30       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.